Cancer Staging & Therapy Guide · Molecular Diagnostics & Therapy

Thyroid Cancer Care
Consultation, Diagnosis & Expert Care

Specialized post-surgical staging, Radioactive Iodine (I-131) remnant ablation (30 to 200 mCi), Whole Body Iodine Scanning, and long-term surveillance by Dr. Nikunj Jain.

Hashimoto's Autoimmune TSH & Free T4 Panel Levothyroxine Guidance Dr. Nikunj Jain (18+ Yrs Exp)
← All Conditions
Overview & Clinical Care

Hypothyroidism Consultation and Care — Under One Roof.

Differentiated thyroid cancer (Papillary and Follicular carcinoma) is highly treatable when managed through a coordinated, multi-modal healthcare approach. Following total or near-total thyroidectomy, Radioactive Iodine (I-131) Therapy is used to destroy microscopic residual thyroid remnant tissue, clear occult cancer cells, and enable sensitive long-term follow-up using blood Thyroglobulin (Tg) tracking.

At Molecular Diagnostics and Therapy, patients requiring nuclear medicine evaluation after thyroid cancer surgery can access specialist consultation, diagnostic Whole Body Iodine Scans, neck ultrasound, blood panels, and Radioiodine (I-131) Therapy within the same integrated setup.

Thyroid Hormones
Thyroxine (T4) & T3 regulate metabolism & body heat.
Consultation
Specialist evaluation by Dr. Nikunj Jain.
Diagnostic Labs
TSH, TSI, Free T4 & antibody panels.
Nuclear Medicine
Thyroid Scans & Gamma imaging when indicated.
Personalized Care
Levothyroxine dosing tailored to body weight & age.
Regional Network
Streamlined care across Delhi NCR & North India.
Understanding The Disease

What Is Differentiated Thyroid Cancer?

Differentiated thyroid cancer (DTC) arises from follicular thyroid cells and comprises Papillary Thyroid Carcinoma (PTC) and Follicular Thyroid Carcinoma (FTC). Because DTC cells retain the unique biological capacity to absorb iodine, radioactive iodine can be targeted directly to thyroid tissue.

After surgical thyroidectomy, administering Radioactive Iodine (I-131) eliminates remaining normal thyroid remnant tissue as well as microscopic or metastatic cancer deposits throughout the body without surgery.

Etiology

Types of Thyroid Cancer & Staging

Proper histological classification and risk stratification determine the exact radioiodine dose required.

Most Common (85%)
Papillary Thyroid Carcinoma
The most common form of thyroid cancer. Generally slow-growing with excellent long-term response to surgical resection and I-131 ablation.
Second Common (10-15%)
Follicular Thyroid Carcinoma
Tends to occur in slightly older adults. Requires evaluation for capsular/vascular invasion and potential distant spread.
Regional Spread
Lymph Node Metastases (N1a / N1b)
Spread to central or lateral neck lymph nodes, requiring comprehensive post-operative imaging and 100 mCi I-131 therapy.
Lung & Bone Spread
Distant Metastatic Disease (M1)
Iodine-avid metastases to lungs or bones managed with maximum-dose 200 mCi I-131 therapy under specialist supervision.
Clinical Signs

Key Indicators & Surveillance Markers

Common signs, symptoms, and post-operative surveillance parameters for thyroid cancer.

Neck lump or thyroid nodule
A firm, painless mass at the front of the neck.
Swollen cervical lymph nodes
Persistent enlargement of lymph nodes in the neck.
Hoarseness or voice changes
Voice roughness due to vocal cord nerve compression.
Difficulty swallowing (Dysphagia)
Pressure sensation when swallowing foods or liquids.
Neck tightness or pain
Discomfort radiating to ears or upper neck.
Elevated Thyroglobulin (Tg)
Rising blood Thyroglobulin levels after thyroidectomy.
Whole Body Scan remnant uptake
Tracer absorption in neck bed or distant sites.
Positive neck ultrasound findings
Structural nodular recurrence in thyroid bed.
High Anti-Tg antibody levels
Auto-antibodies requiring careful Tg monitoring.
TSH suppression requirement
Levothyroxine dosing adjusted to suppress TSH.
Periodic 6-12 month surveillance
Routine follow-up scans and blood marker checks.
SPECT-CT anatomical fusion
Precision 3D imaging for complex neck lesions.

Regular long-term follow-up with blood Thyroglobulin testing and diagnostic Whole Body Iodine Scans is essential for detecting any cancer recurrence at an early stage.

Lab Evaluation

Post-Operative Staging Pathway

A structured step-by-step pathway following thyroid cancer surgery.

01
Surgical Pathology Review
Review of tumor size, surgical margins, capsular invasion, and lymph node histology by Dr. Nikunj Jain.
02
Baseline Thyroglobulin (Tg) & Anti-Tg
Blood testing performed under TSH stimulation (withdrawal or Thyrogen) to measure tumor marker baseline.
03
Diagnostic Whole Body I-131 Scan
Gamma camera sweep to assess post-surgical remnant volume and rule out distant metastases.
04
Radioiodine Dose Selection & Ablation
Prescribing the optimal I-131 activity (30 mCi, 50 mCi, 100 mCi, or 200 mCi) based on risk classification.
Nuclear Imaging

Whole Body Iodine (I-131) Scan for Cancer Staging

A Whole Body Iodine Scan is a specialized nuclear medicine study performed after thyroidectomy and radioiodine therapy. It sweeps the entire body to locate any remaining thyroid tissue or thyroid cancer spread.

The scan provides crucial functional information not visible on routine ultrasound or CT scans, ensuring accurate post-therapy staging and total peace of mind during long-term cancer surveillance.

Nuclear Medicine Assessment at MDT

At Molecular Diagnostics and Therapy, our Nuclear Medicine specialists evaluate whether Technetium-99m / I-131 Thyroid Scanning or high-resolution ultrasound is required based on individual clinical indications.

Explore Advanced Thyroid Scan Details →
Clinical Treatment

Radioactive Iodine (I-131) Therapy Protocols

30 mCi I-131 Remnant Ablation
Standard outpatient oral dose for low-risk differentiated thyroid cancer post-thyroidectomy to destroy microscopic remnant tissue.
50 & 100 mCi I-131 Therapy
Intermediate to high-dose therapeutic protocols for intermediate/high-risk DTC, gross extrathyroidal extension, or lymph node metastases.
200 mCi I-131 Metastatic Protocol
Maximum therapeutic radioiodine dose for iodine-avid pulmonary or skeletal bone metastases, administered in dedicated nuclear suites.
Oncology Follow-Up Care

Thyroid Cancer Follow-Up Care

Following radioiodine ablation, patients require lifelong Levothyroxine therapy to replace missing thyroid hormones and suppress TSH (Thyroid-Stimulating Hormone), preventing cancer cell stimulation.

Periodic surveillance includes blood Thyroglobulin (Tg) testing every 6 to 12 months, high-resolution neck ultrasound, and diagnostic Whole Body Iodine Scans when clinically indicated within MDT's integrated setup.

Explore Radioactive Iodine Therapies
Dr. Nikunj Jain
Expert Leadership

Dr. Nikunj Jain

Founder & HOD – Nuclear Medicine
18+ Years
Nuclear Medicine Exp
75,000+
PET-CT & Scans

Dr. Nikunj Jain, Founder and HOD – Nuclear Medicine at Molecular Diagnostics and Therapy and Molecular Path Labs, brings more than 18 years of Nuclear Medicine experience. He specializes in post-operative thyroid cancer staging, whole-body gamma scans, diagnostic I-131 sweeps, and therapeutic radioiodine ablation (30 mCi to 200 mCi).

Integrated Setup

Why Choose Molecular Diagnostics and Therapy for Thyroid Cancer Care?

At Molecular Diagnostics and Therapy, patients receive comprehensive thyroid cancer care — from post-surgical staging and Whole Body Scans to specialized Radioiodine (I-131) Therapies — all within one integrated setup.
Led by Dr. Nikunj Jain (18+ years experience, 75,000+ PET-CT scans, Gamma Scans, and Radioiodine Therapies), our team ensures precise dosing, radiation safety, and personalized follow-up.
Patients across Delhi NCR and North India benefit from seamless continuity of care, eliminating the need to travel between separate diagnostic labs and therapy centers.
Regional Access

Thyroid Cancer Care Across Delhi NCR & North India

With Dr. Nikunj Jain's nuclear medicine leadership and advanced imaging, patients from Delhi NCR, Ghaziabad, Noida, West UP, Haryana, Punjab, and Uttarakhand access streamlined cancer staging and radioiodine therapy.

📍 Delhi NCR 📍 Ghaziabad 📍 Noida 📍 West UP 📍 Haryana 📍 Punjab 📍 Uttarakhand
Take The Right Step

Take the Right Step for Your Thyroid Cancer Care

Thyroid cancer has an excellent prognosis when treated with expert surgery, timely Radioiodine (I-131) ablation, and diligent long-term surveillance.

Contact Our Center